HHS Secretary Robert F. Kennedy Jr. has rescinded the HHS policy of requiring new rules and regulations to be open to public comment before they are implemented.

Using AI-enabled tools to automatically deny more and more needed care is not the reform of prior authorization physicians and patients are calling for,” said AMA President Bruce A. Scott, MD.

The FDA has approved Tevimbra (tislelizumab) for use in combination with chemotherapy as first-line treatment for unresectable or metastatic, PD-L1-positive ESCC.

Dr Francis Collins, the famed geneticist who led the National Institutes of Health for 12 years, has stepped down.

The updated guidelines note that patients with stage IV NSCLC who have EGFR exon 19 deletions or exon 21 L858R substitutions can receive osimertinib plus platinum doublet chemotherapy or amivantamab ...

Though President Trump denied having any connection to Project 2025 on the campaign trail, he has pushed its health policy ...

Discontinuing tyrosine kinase inhibitor maintenance after extended complete molecular response should only be attempted as part of a clinical trial, the researchers say.

A multivariate analysis confirmed the independent prognostic significance of both landmark and longitudinal MRD.

Questions about whether oncologist Dr Thomas Weiner would be permitted to continue practicing medicine intensified after a ProPublica investigation exposed a trail of patient harm tied to his practice ...

At the Tandem Meetings 2025, researchers presented a study of scalp cooling in patients undergoing chemotherapy and ASCT.

The US government has ended funding for thousands of global health programs that provide health care to millions of people.

This is a public health crisis that exacerbates overdiagnosis and threatens the sustainability of health systems,” said Ray Moynihan, PhD.